11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Gene therapy for psoriasis in the K14-VEGF transgenic mouse model by topical transdermal delivery of interleukin-4 using ultradeformable cationic liposome.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Topical transdermal gene delivery to the skin shows great potential for painless, non-invasive administration of vaccines and therapeutic agents. Interleukin (IL)-4 strategies have shown a good antipsoriatic effect in clinic trials. To date, no information has been acquired on the effectiveness of gene therapy for psoriasis in the K14-VEGF transgenic mouse model by topical transdermal penetration of murine IL-4 (mIL-4) using ultradeformable cationic liposome (UCL).

          Related collections

          Author and article information

          Journal
          J Gene Med
          The journal of gene medicine
          Wiley-Blackwell
          1521-2254
          1099-498X
          Jun 2010
          : 12
          : 6
          Affiliations
          [1 ] State Key Laboratory of Biotherapy, West China Hospital, and School of life Science, Sichuan University, Chengdu, China. lijionghh@sohu.com
          Article
          10.1002/jgm.1459
          20527041
          06d992d4-c2ee-4064-b134-a5e1f9233dcb
          History

          Comments

          Comment on this article